期刊文献+

嗜麦芽窄食单胞菌耐药性分析 被引量:4

Analysis of stenotrophomonas maltoppilia' s drug resistance
下载PDF
导出
摘要 目的:分析嗜麦芽窄食单胞菌的耐药性以指导临床合理用药。方法:对经VITEK系统鉴定出101株嗜麦芽窄食单胞菌进行自动化药敏试验和纸片扩散法药敏试验,同时对长期难治性嗜麦芽窄食单胞菌感染患者每间隔1周进行1次药敏试验。结果:在所有临床标本中从痰液分离的嗜麦芽窄食单胞菌最多(75%),其次是洁尿(10%),该菌对亚胺培南天然耐药,氨苄西林、阿莫西林/棒酸、头孢唑啉、呋喃妥因、头孢呋辛为100%耐药。丁胺卡那、氨曲南、头孢美唑、头孢曲松、头孢噻肟、庆大霉素敏感率在20%以下,对左氧氟沙星、复方新诺明、头孢他啶、头孢哌酮/舒巴坦(舒普深)耐药率分别为18.92%、22.86%、13.95%、2.50%。结论:嗜麦芽窄食单胞菌为医院感染的重要病原菌,对大多数抗生素耐药,头孢哌酮/舒巴坦(舒普深)为其首选药物;嗜麦芽窄食单胞菌对仅有的几个敏感药物也易产生药物诱导性耐药。 Objective:To analyse the drug resistance of the stenotrophomonas maltophilia in order to guide rational drug using in clinical. Methods: The automatic drug sensitive test and method that the paper spreads medicine sensitive test were carried on to 101 stems of the stenotrophomonas maltophilia with the index of the VITEK system, and drug sensitive test with long-term difficult to treat nature's stenotrophomonas maltophilia infection patient was carried once a week. Results:In all clinical samples,stenotrophomonas maltophilia separated from phlegm liquid is the most (75% ) , then is the clear urine( 10% ) ,this fungus is nature resistance to the action of the iminepinan. The drug resistance of ampicillin,amoxicillin/clavulanic acid,cefazolin,furantoin,cefuroxime are 100% . Amika-cin, aztreonam, cefmetazole, ceftriaxone, cefotaxime, gentamicin's sensitive rate are under 20% , for levofloxacin, Compound sinomin, ceftazidime,cefoperazone/sulbactam,the drug resistance is 18.92% ,22.86% ,13.95% ,2.50% respectively. Conclusion:Stenotrophomonas maltophilia is the important pathogen fungus that infects in hospital, and resistance to most of the antibiotics, Cefoperazone/sul-bactam is the first-selected medicine for it; Stenotrophomonas maltophilia is easy to produce medicament inductivity resistance to a few sensitive drugs.
出处 《药学实践杂志》 CAS 2004年第5期271-273,共3页 Journal of Pharmaceutical Practice
关键词 嗜麦芽窄食单胞菌 外排泵系统 多重耐药 stenotrophomonas maltophilia extra-pumping system multi-drug resistance
  • 相关文献

参考文献7

  • 1张军民,赵莉萍,吴坚,程彦国.嗜麦芽窄食单胞菌简易鉴定方法探讨[J].中华医学检验杂志,1998,21(2):115-115. 被引量:35
  • 2袁应华.嗜麦芽窄食单胞菌150株耐药性分析[J].上海铁道大学学报,2000,21(3):24-25. 被引量:2
  • 3孙二琳,宋诗铎.嗜麦芽寡养单胞菌耐药机制的研究[J].中国抗生素杂志,2003,28(7):445-448. 被引量:22
  • 4[4]Valdezate S,Vindel A,Echeta A,et al.Antimicrobial susceptibilities of unique Stentrophomonas maltophilia clinical strains[J].Antimicrob Agents Chemother,2001,45(5):1581.
  • 5[5]Avison MB, Higgins CS, Ford PJ. Differential regulation of L1 and L2 betalacta mase expression in Stenotrophomonas maltophilia [J].J Antimicrob Chemother,2002,44(7):1778.
  • 6[6]Denton M,Todd NJ,Kerr KG,et al.Molecular epide midogy of Stenoterphomonas maltophilia isolated from clinical spcimens from patients with cystic fibrosis and associated environ mental samples[J].J Clin Microbiol,1998,36(7):1953.
  • 7[7]Valdezate S,Vindel A,Loza E,et al.Topoisomerase Ⅱ and Ⅳ quinolone resistance determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility [J].Antimicrob Agents Chemother,2002,46(3):665.

二级参考文献19

  • 1Valdezate S, Vindel A, Loza E, et al. Topoisomerase Ⅱ and Ⅳ quinolone resistance- determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility [J]. Antimicrob Agents Chemother,2002,46(3) : 665.
  • 2Valdezate S, Vindel A, Echeita A. et al. Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains [J]. Antimicrob Agents Chemother, 2001,45(5) : 1581.
  • 3Pan F F, Jin Y H, Ma J H, et al. Clinical analysis and antimicrobial susceptibility of nosocomial stenotrophomon as maltophilia [J]. Chin J Nosocom, 2001,11 (6) ; 409.
  • 4Wang B Q, Hu B J, He L X. Stenotrophomonas maltophilia with multiple antimicrobial resistance in hospital[J]. Chin J Nosocom ,1999,9(4) :252.
  • 5Yang L J, Lin G Q, Wang S L, et al. Clinical predisposition and antimicrobial resistance of Stenotrophomonas maltophilia [J]. Chin J Nosocom, 1999,9(3) : 140.
  • 6Lin L M, Chen R, Xiang M J. Analysis of clinical characteristics and antimicrobial resistence of Stenotrophomonas maltophilia [J]. Chin J Nosocom, 2000, 10(Suppl) : 282.
  • 7Aloson A, Jose M L. Multiple antibiotic resistance in Stenotrophornonas rnaltophilia [J]. Antirnicrob Agents Chemother, 1997,41 (5) : 1140.
  • 8Zhang L, Li X Z, Poole K. SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia [J]. Antimicrob Agents Chemother,2001,45(12 ) :3497.
  • 9Zhang L, Li X Z, Poole K. SmeC, a outer membrane multidrug efflux protein of Stenotrophomonas maltophilia[J]. Antimicrob Agents Chemother , 2002,2 : 333.
  • 10Avison M B, Higgins C S, Ford P J. Differential regulation of L1 and L2 beta-lactamase expression in Stenotrophomonas maltophilia [J]. J Antilnicrob Chemother ,2002,44 (7) : 1778.

共引文献53

同被引文献18

  • 1贾延伟,周惠琴.嗜麦芽窄食单胞菌的临床检出及耐药性调查[J].临床输血与检验,2005,7(2):128-129. 被引量:6
  • 2段金菊,刘卓拉,张润梅,张瑞琴,杜娟,刘国栋,徐辉,康建帮.2001—2005年某院抗生素使用情况及革兰阴性细菌耐药性分析[J].中国药物与临床,2007,7(2):98-102. 被引量:9
  • 3林壮,唐蕾,崔颖鹏,曾燕,建美,陈求刚.173株嗜麦芽窄食单胞菌的菌群分布及对常用抗生素的药物敏感分析[J].中国微生态学杂志,2007,19(2):218-218. 被引量:8
  • 4Hellmig S, Ott S, Musfekdt M, et al. Life-threatening chronic enteritis due to colonization of the small bowel with Stenotrophomonas maltophilia [ J].Gastroenterology, 2005,129(2) :706-712.
  • 5Ghen YF, Chtmg PC, Hsiao CH.Stenotrophomonas maltophilia keratitis and scleritis[ J]. Chang Gung Med J,2005,28(3) : 142-150.
  • 6Valdezate S, Vindel A, SaeZ-Nieto JA, et al. Preservation of topoisemerase genetic sequences during in vivo and in vitro development of high-level resistanee to eiprofloxaein in isogenie Stenotrophomonas mahophilia strains[J] .J Antimierob Chemother,2005,56(1) :220-223.
  • 7Qamruddin AO, Alkawash MA, Soothill JS.Antibiotie susceptibility of Stenotrophomonas mahophilia in the presence of lactoferrin [ J]. Antimicrob AgentsChemother, 2005,49 (10) : 4425-4426.
  • 8Sanchez P, Alonso A, Martinez JL. Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains ex- pressing different amounts of the multidrug efflux pump SmeDEF [J]. Antimicrob Agents Chemother, 2004, 48 (6) : 2274-2276.
  • 9Gould VC, Avison MB. SmeDEF-mediated antimicrobial drug resistance in Stenotrophomonas maltophilia clinical isolates having defined phylogenetic relationships[J]. J Antimicrob Chemother,2006,57(6) : 1070-1076.
  • 10Valdezate S, Vindel A, Saez-Nieto JA, et al. Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains [J]. J Antimicrob Chemother, 2005,56 (1) : 220-223.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部